NFKB1 and Miyoshi myopathy: Two reports have highlighted the relationship between NF-κB gene expression signature and genetic abnormalities in regulators of the alternative NF-κB signaling cascades in 9% [32] and 17% [31] of patient cohorts with MM, suggesting the biological significance of the alternative NF-κB pathway in MM pathogenesis.